+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Cell Culture Protein Surface Coatings Market - Growth, Trends, and Forecast (2020 - 2025)

  • ID: 5176198
  • Report
  • August 2020
  • Region: Global
  • 114 Pages
  • Mordor Intelligence


  • Abcam PLC
  • Corning Incorporated
  • Promega Corporation
  • Qiagen NV
The cell culture protein surface coatings market is expected to register a CAGR of nearly 9.5%, during the forecast period. The optimization of cell culture environment enables cells to grow, function, and survive in a realistic and representative manner. The surface coating of cell culture with protein involves coating the cell culture surface with extracellular matrix or protein components, in order to improve the proliferation and adhesion of the cells in-vitro. Corning is among the oldest companies advanced in the cell-culture surface technology, with a long legacy of developing new surfaces with expanded capabilities.

Some of the major drivers for this market include increasing research related to stem cells. Recent years have witnessed the high importance of stem cells in treating many chronic diseases, and it has been observed that stem cells have great potential for cell therapy, protein cell culture, tissue engineering, and regenerative medicine. The other drivers include growing demand for protein therapeutics and targeted therapy, as well as a steady increase in the preference toward 3D cell cultures over 2D cell cultures. However, there are several government laws and individual societies’ norms, which inhibit the use of animal-sourced protein coating. This restricts the growth of the overall market, along with the high cost associated with cell culture protein.

Key Market Trends

Synthetic Proteins are Expected to Provide Fast Growth for the Market over the Forecast Period

Consequently, artificial proteins are the leading category of protein sources in the cell culture protein surface coatings market. The synthetic proteins have a relatively lower risk proposition, as they are less prone to contamination. There is a wide range of applications observed by scientific researchers in their studies, such as the potential early treatment of diseases like cancer and diabetes. There is a growing application related to protein therapeutics and technological advancement. Moreover, it is an alternative origin of animal source, which drives its importance in research communities and markets. Thus, it is estimated to grow the fastest, over the forecast period.

North America is Estimated to Hold the Largest Share in the Market

North America is well known for its cell culture laboratories and funding for research in the healthcare domain. Every year, in the United States, the National Institutes of Health (NIH) heavily funds stem cell research. For research in cancer diseases and personalized medicine, the National Cancer Institute (NCI) allocates high funds to universities and companies collaborating with research centers. Such factors boost the importance of cell culture activities. The healthcare expenditure is, therefore, high in the United States and Canada.

Competitive Landscape

The major market players are focusing on technological advancements in protein technology and cell culture techniques. Some of the major players in the market are Corning Incorporated, Greiner Bio-One International AG, Merck Millipore, Qiagen NV, and Thermo Fisher Scientific Inc.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Note: Product cover images may vary from those shown


  • Abcam PLC
  • Corning Incorporated
  • Promega Corporation
  • Qiagen NV

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Inceasing Stem Cell Research Activities
4.2.2 Increasing Demand of Protein Therapeutics and Targeted Therapy
4.2.3 Growing Preference for 3D Cell Cultures over 2D Cell Cultures
4.3 Market Restraints
4.3.1 High Cost of Cell Culture Protein Surface Coatings Products
4.3.2 Restriction Against Use of Animal Source Protein Coating Material
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Protein Source
5.1.1 Animal-derived Protein
5.1.2 Human-derived Protein
5.1.3 Synthetic Protein
5.1.4 Plant-derived Protein
5.2 By Type of Coating
5.2.1 Self-coating
5.2.2 Pre-coatings Microwell Plates Petri Dish Flask Slides Other Types of Pre-coatings
5.3 By Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe France Germany United Kingsom Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.3.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Abcam PLC
6.1.2 Corning Incorporated
6.1.3 Greiner Bio-One International AG
6.1.4 Meark KGaA (Merck Millipore)
6.1.5 Promega Corporation
6.1.6 Qiagen NV
6.1.7 Sartorius Stedim Biotech SA
6.1.8 Thermo Fisher Scientific Inc.
6.1.9 Viogene BioTek Corporation
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abcam PLC
  • Corning Incorporated
  • Greiner Bio-One International AG
  • Meark KGaA (Merck Millipore)
  • Promega Corporation
  • Qiagen NV
  • Sartorius Stedim Biotech SA
  • Thermo Fisher Scientific Inc.
  • Viogene BioTek Corporation
Note: Product cover images may vary from those shown